Example of Pharmacoepidemiology and Drug Safety format
Recent searches

Example of Pharmacoepidemiology and Drug Safety format Example of Pharmacoepidemiology and Drug Safety format Example of Pharmacoepidemiology and Drug Safety format Example of Pharmacoepidemiology and Drug Safety format Example of Pharmacoepidemiology and Drug Safety format Example of Pharmacoepidemiology and Drug Safety format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Pharmacoepidemiology and Drug Safety format Example of Pharmacoepidemiology and Drug Safety format Example of Pharmacoepidemiology and Drug Safety format Example of Pharmacoepidemiology and Drug Safety format Example of Pharmacoepidemiology and Drug Safety format Example of Pharmacoepidemiology and Drug Safety format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Pharmacoepidemiology and Drug Safety — Template for authors

Publisher: Wiley
Categories Rank Trend in last 3 yrs
Pharmacology (medical) #80 of 246 up up by 1 rank
Epidemiology #43 of 99 up up by 1 rank
journal-quality-icon Journal quality:
Good
calendar-icon Last 4 years overview: 705 Published Papers | 3132 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 07/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

Taylor and Francis

Quality:  
High
CiteRatio: 6.4
SJR: 1.187
SNIP: 1.192
open access Open Access

SAGE

Quality:  
High
CiteRatio: 6.1
SJR: 1.333
SNIP: 1.061
open access Open Access

SAGE

Quality:  
High
CiteRatio: 4.8
SJR: 1.164
SNIP: 1.22
open access Open Access

SAGE

Quality:  
High
CiteRatio: 6.3
SJR: 1.196
SNIP: 1.603

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

2.918

2% from 2018

Impact factor for Pharmacoepidemiology and Drug Safety from 2016 - 2019
Year Value
2019 2.918
2018 2.87
2017 2.314
2016 2.552
graph view Graph view
table view Table view

4.4

2% from 2019

CiteRatio for Pharmacoepidemiology and Drug Safety from 2016 - 2020
Year Value
2020 4.4
2019 4.5
2018 4.1
2017 4.1
2016 4.7
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has increased by 2% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has decreased by 2% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

1.023

16% from 2019

SJR for Pharmacoepidemiology and Drug Safety from 2016 - 2020
Year Value
2020 1.023
2019 1.223
2018 1.519
2017 1.329
2016 1.513
graph view Graph view
table view Table view

1.227

7% from 2019

SNIP for Pharmacoepidemiology and Drug Safety from 2016 - 2020
Year Value
2020 1.227
2019 1.148
2018 1.167
2017 0.989
2016 1.175
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has decreased by 16% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 7% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Pharmacoepidemiology and Drug Safety

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Wiley

Pharmacoepidemiology and Drug Safety

The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews a...... Read More

Pharmacology (medical)

Epidemiology

Medicine

i
Last updated on
06 Jun 2020
i
ISSN
1053-8569
i
Impact Factor
High - 1.393
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Yellow faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
apa
i
Citation Type
Numbered
[25]
i
Bibliography Example
Beenakker, C.W.J. (2006) Specular andreev reflection in graphene.Phys. Rev. Lett., 97 (6), 067 007. URL 10.1103/PhysRevLett.97.067007.

Top papers written in this journal

Journal Article DOI: 10.1002/PDS.1294
The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months

Abstract:

The new Swedish Prescribed Drug Register-Opportunities for pharmacoepidemiological research and experience from the first six months.

Topics:

Drug Utilization (54%)54% related to the paper, Pharmacoepidemiology (52%)52% related to the paper
1,429 Citations
Journal Article DOI: 10.1002/PDS.2087
Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan.
Ching Lan Cheng1, Yea Huei Yang Kao1, Swu Jane Lin2, Cheng Han Lee1, Ming Liang Lai1

Abstract:

Objective The National Health Insurance Research Database (NHIRD) is commonly used for pharmacoepidemiological research in Taiwan. This study evaluated the validity of the database for patients with a principal diagnosis of ischemic stroke. Study design and methods This cross-sectional study compares records in the NHIRD... Objective The National Health Insurance Research Database (NHIRD) is commonly used for pharmacoepidemiological research in Taiwan. This study evaluated the validity of the database for patients with a principal diagnosis of ischemic stroke. Study design and methods This cross-sectional study compares records in the NHIRD with those in one medical center. Patients hospitalized for ischemic stroke in 1999 were identified from both databases. The discharge notes, laboratory data, and medication orders during admission and the first discharge visit were reviewed to validate ischemic stroke diagnoses and aspirin prescribing in the NHIRD. Agreement between the two databases in comorbidities of ischemic stroke diagnosis was evaluated using ICD-9 codes. Results Three hundred and seventy two cases were identified from the NHIRD; among them, 364 cases (97.85%) were confirmed as ischemic stroke by radiology examination and clinical presentation. Among these confirmed cases, 344 (94.51%) were assigned ‘ischemic stroke’ as the principal diagnosis in the NHIRD. The overall agreement of comorbid diagnoses between the databases was 48.39%. The PPV for selected conditions also varied widely, from 0.50 for fracture to 1.00 for colon cancer. The accuracy of recorded aspirin prescriptions was higher in first post-discharge visits (PPV = 0.94) than during hospitalization (PPV = 0.88). Conclusion The accuracy of the NHIRD in recording ischemic stroke diagnoses and aspirin prescriptions was high, and the NHIRD appears to be a valid resource for population research in ischemic stroke. Copyright © 2010 John Wiley & Sons, Ltd. read more read less
1,131 Citations
Journal Article DOI: 10.1002/PDS.677
Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports
Stephen J. W. Evans, Patrick Waller, S. Davis

Abstract:

BACKGROUND: The process of generating 'signals' of possible unrecognized hazards from spontaneous adverse drug reaction reporting data has been likened to looking for a needle in a haystack. However, statistical approaches to the data have been under-utilised. METHODS: Using the UK Yellow Card database, we have developed and ... BACKGROUND: The process of generating 'signals' of possible unrecognized hazards from spontaneous adverse drug reaction reporting data has been likened to looking for a needle in a haystack. However, statistical approaches to the data have been under-utilised. METHODS: Using the UK Yellow Card database, we have developed and evaluated a statistical aid to signal generation called a Proportional Reporting Ratio (PRR). The proportion of all reactions to a drug which are for a particular medical condition of interest is compared to the same proportion for all drugs in the database, in a 2 x 2 table. We investigated a group of newly-marketed drugs using as minimum criteria for a signal, 3 or more cases, PRR at least 2, chi-squared of at least 4. FINDINGS: The database was used to examine retrospectively 15 drugs newly-marketed in the UK, with the highest levels of ADR reporting. The method identified 481 signals meeting the minimum criteria during the period 1996-8. Further evaluation of these showed that 70% were known adverse reactions, 13% were events which were likely to be related to the underlying disease and 17% were signals requiring further evaluation. IMPLICATIONS: Proportional reporting ratios are a valuable aid to signal generation from spontaneous reporting data which are easy to calculate and interpret, and various refinements are possible. read more read less

Topics:

Adverse Event Reporting System (59%)59% related to the paper, Adverse drug reaction (51%)51% related to the paper
975 Citations
Journal Article DOI: 10.1002/PDS.1230
Methods for evaluation of medication adherence and persistence using automated databases.
Susan E. Andrade1, Kristijan H. Kahler2, Feride Frech2, K. Arnold Chan3

Abstract:

Purpose Our aim was to perform a systematic review of the methods currently being used to assess adherence and persistence in pharmacoepidemiological and pharmacoeconomic studies using automated databases. Methods A MEDLINE search of English language literature was performed to identify studies published between ... Purpose Our aim was to perform a systematic review of the methods currently being used to assess adherence and persistence in pharmacoepidemiological and pharmacoeconomic studies using automated databases. Methods A MEDLINE search of English language literature was performed to identify studies published between January 1, 1980 and March 31, 2004 that evaluated adherence, compliance, persistence, switching, or discontinuations of medications using automated dispensing data (pharmacy records). Two study investigators independently reviewed the abstracts and articles to determine relevant studies according to specified criteria. Results A total of 136 articles met the criteria for evaluation. The types of measures of adherence and persistence commonly reported include the medication possession ratio and related measures of medication availability (77 studies), discontinuation/continuation (58 studies), switching (34 studies), medication gaps (13 studies), refill compliance (7 studies), and retentiveness/turbulence (4 studies). Specific issues considered include the assessment of exposed time to drug therapy and specification of the follow-up period. Conclusions The terminology, definitions, and methods to determine adherence and persistence differ greatly in the published literature. The appropriateness and choice of the specific measure employed should be determined by the overall goals of the study, as well as the relative advantages and limitations of the measures. Copyright © 2006 John Wiley & Sons, Ltd. read more read less
952 Citations
Journal Article DOI: 10.1002/PDS.668
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.

Abstract:

SUMMARY Purpose A continuous systematic review of all combinations of drugs and suspected adverse reactions (ADRs) reported to a spontaneous reporting system, is necessary to optimize signal detection. To focus attention of human reviewers, quantitative procedures can be used to sift data in different ways. In various centres... SUMMARY Purpose A continuous systematic review of all combinations of drugs and suspected adverse reactions (ADRs) reported to a spontaneous reporting system, is necessary to optimize signal detection. To focus attention of human reviewers, quantitative procedures can be used to sift data in different ways. In various centres, different measures are used to quantify the extent to which an ADR is reported disproportionally to a certain drug compared to the generality of the database. The objective of this study is to examine the level of concordance of the various estimates to the measure used by the WHO Collaborating Centre for International ADR monitoring, the information component (IC), when applied to the dataset of the Netherlands Pharmacovigilance Foundation Lareb. Methods The Reporting Odds Ratio � 1.96 standard errors (SE), proportional reporting ratio � 1.96 SE, Yule’s Q � 1.96 SE, the Poisson probability and Chi-square test of all 17 330 combinations were compared with the IC minus 2 standard deviations. Additionally, the concordance of the various tests, in respect to the number of reports per combination, was examined. Results In general, sensitivity was high in respect to the reference measure when a combination of point- and precision estimate was used. The concordance increased dramatically when the number of reports per combination increased. Conclusion This study shows that the different measures used are broadly comparable when four or more cases per combination have been collected. Copyright # 2002 John Wiley & Sons, Ltd. read more read less

Topics:

Adverse Event Reporting System (51%)51% related to the paper, Concordance (50%)50% related to the paper
View PDF
766 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Pharmacoepidemiology and Drug Safety.

It automatically formats your research paper to Wiley formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Pharmacoepidemiology and Drug Safety format uses apa citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Pharmacoepidemiology and Drug Safety in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Pharmacoepidemiology and Drug Safety guidelines and auto format it.

2. Do you follow the Pharmacoepidemiology and Drug Safety guidelines?

Yes, the template is compliant with the Pharmacoepidemiology and Drug Safety guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Pharmacoepidemiology and Drug Safety?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Pharmacoepidemiology and Drug Safety citation style.

4. Can I use the Pharmacoepidemiology and Drug Safety templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Pharmacoepidemiology and Drug Safety.

5. Can I use a manuscript in Pharmacoepidemiology and Drug Safety that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Pharmacoepidemiology and Drug Safety that you can download at the end.

6. How long does it usually take you to format my papers in Pharmacoepidemiology and Drug Safety?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Pharmacoepidemiology and Drug Safety.

7. Where can I find the template for the Pharmacoepidemiology and Drug Safety?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Pharmacoepidemiology and Drug Safety's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Pharmacoepidemiology and Drug Safety's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Pharmacoepidemiology and Drug Safety an online tool or is there a desktop version?

SciSpace's Pharmacoepidemiology and Drug Safety is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Pharmacoepidemiology and Drug Safety?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Pharmacoepidemiology and Drug Safety?”

11. What is the output that I would get after using Pharmacoepidemiology and Drug Safety?

After writing your paper autoformatting in Pharmacoepidemiology and Drug Safety, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Pharmacoepidemiology and Drug Safety's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Pharmacoepidemiology and Drug Safety?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Pharmacoepidemiology and Drug Safety. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Pharmacoepidemiology and Drug Safety?

The 5 most common citation types in order of usage for Pharmacoepidemiology and Drug Safety are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Pharmacoepidemiology and Drug Safety?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Pharmacoepidemiology and Drug Safety's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Pharmacoepidemiology and Drug Safety in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Pharmacoepidemiology and Drug Safety Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Pharmacoepidemiology and Drug Safety formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template